Skip to main content
. 2016 Sep;28(3):131–137.

Table S1.

Fraction of eligible participants in each treatment group who experienced minor complications during treatment.

Complication Nasal
Oxygen
bCPAP Transitioned from
nasal oxygen to
bCPAP
Mild facial irritation, < 1 day duration 3 (12%) 1 (1.9%) 0 (0.0%)
Mild nasal irritation, < 3 day duration 1 (4.0%) 7 (13.2%) 2 (22.2%)
Mild epistaxis 1 (4.0%) 6 (11.3%) 2 (22.2%)